ID: ALA5277205

Max Phase: Preclinical

Molecular Formula: C22H24F6N8OS

Molecular Weight: 562.54

Associated Items:

Representations

Canonical SMILES:  C[C@@H]1CN(c2sc(C(F)(F)F)nc2-c2cnc(C(F)(F)F)nc2)CCN1C(=O)Cn1cnc(C(C)(C)C)n1

Standard InChI:  InChI=1S/C22H24F6N8OS/c1-12-9-34(5-6-36(12)14(37)10-35-11-31-17(33-35)20(2,3)4)16-15(32-19(38-16)22(26,27)28)13-7-29-18(30-8-13)21(23,24)25/h7-8,11-12H,5-6,9-10H2,1-4H3/t12-/m1/s1

Standard InChI Key:  GHQQXFVYIYQRDG-GFCCVEGCSA-N

Associated Targets(Human)

C-X-C chemokine receptor type 3 2736 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HERG 29587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 562.54Molecular Weight (Monoisotopic): 562.1698AlogP: 4.26#Rotatable Bonds: 4
Polar Surface Area: 92.93Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 1.92CX LogP: 4.92CX LogD: 4.92
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.44Np Likeness Score: -1.33

References

1. Meyer EA, Äänismaa P, Ertel EA, Hühn E, Strasser DS, Rey M, Murphy MJ, Martinic MM, Pouzol L, Froidevaux S, Keller MP, Caroff E..  (2023)  Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies.,  66  (6): [PMID:36883854] [10.1021/acs.jmedchem.3c00074]

Source